Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,066.00
Bid: 3,089.00
Ask: 3,091.00
Change: 67.00 (2.23%)
Spread: 2.00 (0.065%)
Open: 3,047.00
High: 3,117.00
Low: 3,043.00
Prev. Close: 2,999.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Sonatest NDE plc

22 Oct 2010 11:45

RNS Number : 8624U
3i Group PLC
22 October 2010
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

(i) 3i GROUP PLC

 

(ii) 3i PLC

 

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

3i Group plc is the ultimate owner and controller of the interests of 3i plc at (ii) above (namely 22,500 A Ordinary £1 shares).

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SONATEST NDE PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

22/10/2010

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(i) 6,000 Ordinary £1

 

 

 

(ii) 22,500 A Ordinary £1

5.502% of the Ords.,

representing 4.561% of the entire issued share capital.

 

100% of the A Ords.,

representing 17.105% of the entire issued share capital.

 

 

 

 

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

 

(i) 6,000 Ordinary £1

 

 

 

(ii) 22,500 A Ordinary £1

 

5.502% of the Ords.,

representing 4.561% of the entire issued share capital.

 

100% of the A Ords., representing 17.105% of the entire issued share capital.

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

22 October 2010

Contact name:

Toby Vero

Telephone number:

0207 975 3225

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEAEEAALAEFFF
Date   Source Headline
2nd Oct 202310:36 amRNSPortfolio Update
28th Sep 20231:35 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSUpdate on portfolio and Capital Markets Seminar
12th Sep 202310:43 amRNSDirector/PDMR Shareholding
4th Sep 202310:41 amRNSDirector/PDMR Shareholding
31st Aug 20233:56 pmRNSTotal Voting Rights
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding
12th Jun 20232:33 pmRNSPublication of a Prospectus
9th Jun 20239:44 amRNSBlock listing Interim Review
8th Jun 20232:51 pmRNSDirector/PDMR Shareholding
7th Jun 202311:21 amRNSDTR 6.3.5
5th Jun 20233:30 pmRNSDirector/PDMR Shareholding
2nd Jun 20234:12 pmRNSDirector/PDMR Shareholding
31st May 20234:36 pmRNSTotal Voting Rights
31st May 20234:33 pmRNSDirector/PDMR Shareholding
24th May 202310:24 amRNSDoc re. 2023 Notice of AGM
18th May 202311:02 amRNSDoc re. 2023 Annual Report and Accounts
12th May 20232:47 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSResults for the year to 31 March 2023
28th Apr 20234:41 pmRNSTotal Voting Rights
28th Apr 20234:40 pmRNSDirector/PDMR Shareholding
3rd Apr 202310:38 amRNSPortfolio Update
31st Mar 20234:37 pmRNSTotal Voting Rights
31st Mar 20234:34 pmRNSDirector/PDMR Shareholding
28th Mar 202311:36 amRNSDirector/PDMR Shareholding
24th Mar 20232:13 pmRNSDirector/PDMR Shareholding
24th Mar 202312:14 pmRNSDirector/PDMR Shareholding
24th Mar 202312:11 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSAction Capital Markets Seminar & portfolio update
15th Mar 20232:53 pmRNSHolding(s) in Company
28th Feb 20233:41 pmRNSDirector/PDMR Shareholding
28th Feb 20233:31 pmRNSTotal Voting Rights
10th Feb 20231:28 pmRNSHolding(s) in Company
8th Feb 20239:54 amRNSHolding(s) in Company
6th Feb 20232:10 pmRNSDirector/PDMR Shareholding
2nd Feb 202310:44 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.